Novonesis Statistics

Total Valuation

Novonesis has a market cap or net worth of DKK 192.54 billion. The enterprise value is 203.85 billion.

Market Cap	192.54B
Enterprise Value	203.85B

Important Dates

The next estimated earnings date is Thursday, May 8, 2025.

Earnings Date	May 8, 2025
Ex-Dividend Date	Apr 4, 2025

Share Statistics

Novonesis has 465.96 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	465.96M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	27.18%
Float	346.72M

Valuation Ratios

The trailing PE ratio is 50.35 and the forward PE ratio is 29.60. Novonesis's PEG ratio is 3.02.

PE Ratio	50.35
Forward PE	29.60
PS Ratio	6.73
PB Ratio	2.31
P/TBV Ratio	22.41
P/FCF Ratio	37.88
P/OCF Ratio	25.31
PEG Ratio	3.02

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 25.34, with an EV/FCF ratio of 40.10.

EV / Earnings	89.38
EV / Sales	7.13
EV / EBITDA	25.34
EV / EBIT	32.56
EV / FCF	40.10

Financial Position

The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.16.

Current Ratio	1.73
Quick Ratio	1.05
Debt / Equity	0.16
Debt / EBITDA	1.66
Debt / FCF	2.64
Interest Coverage	10.48

Financial Efficiency

Return on equity (ROE) is 4.67% and return on invested capital (ROIC) is 6.61%.

Return on Equity (ROE)	4.67%
Return on Assets (ROA)	5.54%
Return on Invested Capital (ROIC)	6.61%
Return on Capital Employed (ROCE)	5.97%
Revenue Per Employee	2.70M
Profits Per Employee	215,516
Employee Count	10,582
Asset Turnover	0.40
Inventory Turnover	3.05

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +6.36% in the last 52 weeks. The beta is 0.56, so Novonesis's price volatility has been lower than the market average.

Beta (5Y)	0.56
52-Week Price Change	+6.36%
50-Day Moving Average	407.16
200-Day Moving Average	425.71
Relative Strength Index (RSI)	55.50
Average Volume (20 Days)	598,300

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novonesis had revenue of DKK 28.59 billion and earned 2.28 billion in profits. Earnings per share was 8.21.

Revenue	28.59B
Gross Profit	14.87B
Operating Income	6.29B
Pretax Income	3.11B
Net Income	2.28B
EBITDA	8.07B
EBIT	6.29B
Earnings Per Share (EPS)	8.21

Full Income Statement

Balance Sheet

The company has 2.09 billion in cash and 13.40 billion in debt, giving a net cash position of -11.31 billion or -24.28 per share.

Cash & Cash Equivalents	2.09B
Total Debt	13.40B
Net Cash	-11.31B
Net Cash Per Share	-24.28
Equity (Book Value)	83.35B
Book Value Per Share	299.92
Working Capital	5.90B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 7.61 billion and capital expenditures -2.52 billion, giving a free cash flow of 5.08 billion.

Operating Cash Flow	7.61B
Capital Expenditures	-2.52B
Free Cash Flow	5.08B
FCF Per Share	10.91

Full Cash Flow Statement

Margins

Gross margin is 52.00%, with operating and profit margins of 21.99% and 7.98%.

Gross Margin	52.00%
Operating Margin	21.99%
Pretax Margin	10.88%
Profit Margin	7.98%
EBITDA Margin	28.23%
EBIT Margin	21.99%
FCF Margin	17.78%

Dividends & Yields

This stock pays an annual dividend of 6.19, which amounts to a dividend yield of 1.50%.

Dividend Per Share	6.19
Dividend Yield	1.50%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	81.65%
Buyback Yield	-0.64%
Shareholder Yield	0.86%
Earnings Yield	1.18%
FCF Yield	2.64%

Dividend Details

Stock Splits

The last stock split was on November 28, 2011. It was a forward split with a ratio of 5.

Last Split Date	Nov 28, 2011
Split Type	Forward
Split Ratio	5

Scores

Novonesis has an Altman Z-Score of 5.27.

Altman Z-Score	5.27
Piotroski F-Score	n/a